Galena Biopharma, Mills Pharmaceuticals deal

Galena acquired Mills Pharmaceuticals for about $1.6 million cash up front. Galena gains exclusive, worldwide rights to anagrelide

Read the full 189 word article

User Sign In

Article Purchase

This article may not be distributed to non-subscribers

PURCHASE THIS ARTICLE FOR LIMITED ONE-TIME DISTRIBUTION AND WEBSITE POSTING $995.00 USD

PURCHASE